Jpmorgan Chase & Co »

Reviv3 Procare shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Reviv3 Procare (AXIL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Reviv3 Procare

Tip: Access up to 7 years of quarterly data

All positions including Reviv3 Procare held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviv3 Procare by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $46 6 7.67

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Reviv3 Procare

Millennium Management
Geode Capital Management
Susquehanna International
BlackRock
Castleview Partners
Tower Research Capital
Bank of America Corporation
Jpmorgan Chase & Co
UBS Group

View all funds holding Reviv3 Procare